Teradyne reported third quarter memory test revenue of $128 million, representing a 110% sequential increase driven by strong demand for AI-focused high-bandwidth memory (HBM) and DRAM test systems. This growth more than offset weakness in legacy memory segments, with bookings for next-generation devices up 75% compared to the prior quarter. Management highlighted that new AI accelerator deployments accounted for 45% of total memory test orders, underscoring the strategic pivot toward wafer-level solutions tailored to high-performance computing workloads.

For fiscal 2025 fourth quarter, Teradyne provided revenue guidance in the range of $920 million to $1.0 billion and GAAP earnings per share of $1.12 to $1.39. The midpoint implies year-over-year growth of approximately 18% for revenue and a 22% increase in EPS. Leadership attributes this anticipated acceleration to ramping semiconductor test programs at two major foundry customers and the initial contribution from newly qualified AI test platforms. Investors will watch December’s release for confirmation that capital expenditure plans at key chipmakers remain on track.

Teradyne shares currently trade at a 56.99x EV/aEBITDA multiple, representing a 35% premium to its five-year average. While secular trends in AI and industrial robotics underpin long-term upside, the near-term valuation leaves limited margin for execution missteps. Analysts offering a cautious buy rating cite potential volatility around Q4 results, recommending dollar-cost averaging into positions or awaiting a post-earnings pullback. Consensus revenue estimates for FY26 stand at $3.7 billion, with street EPS forecasts of $5.25, implying mid-teens growth next year.

Despite robust tailwinds, Teradyne’s fortunes remain tied to the semiconductor equipment cycle and a small group of hyperscale customers that account for roughly 60% of test revenues. A normalization in chip inventory or a deferral of capital spending at leading foundries could lead to order volatility. Additionally, margin sensitivity to mix shifts—particularly if lower-value legacy tests re-emerge—poses a risk to the company’s high-teens operating profit margins. Investors should monitor monthly booking trends and any shifts in end-customer build plans for early signs of cyclical turn.